Fig. 3From: Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancerAssociations between plasma TIMP-1 and weight loss (a), ferritin (b), FVC (c) cholinesterase (d) and hemoglobin (e) were tested by Spearman correlationsBack to article page